Form D · Pharmaceuticals
Navitor Pharmaceuticals, Inc.
Cambridge, MA · CIK 0001588059
Offering snapshot reported May 7, 2020 · SEC filing
- Reported sold
- $20.2M Offering amount: $20.2M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 21, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 7, 2020 | Initial | $20,186,771 | No comparison | 19 | SEC filing |
| Jan 2, 2019 | Initial | $11,250,003 | No comparison | 12 | SEC filing |
| Mar 16, 2018 | Initial | $11,250,002 | No comparison | 12 | SEC filing |
| Dec 22, 2015 | Initial | $12,000,001 | No comparison | 11 | SEC filing |
| Aug 15, 2014 | Amendment | $13,521,560 | $0vs Jun 26, 2014 | 10 | SEC filing |
| Jun 26, 2014 | Amendment | $13,521,560 | $3,289,586vs Oct 2, 2013 | 10 | SEC filing |
| Oct 2, 2013 | Initial | $10,231,974 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-366438
$5,186,770.87 of the total amount sold reflects cancellation of indebtedness.
Source: Form D, filed May 7, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Bitterman | Director |
| Barry Burgdorf | Director |
| Alan Crane | Director |
| John Creecy | Director, Executive |
| Rajeev Dadoo | Director |
| Jean Francois Formela | Director |
| Paul Friedman | Director |
| Paul Friedman, M.D. | Director |
| Brian Gallagher | Director |
| Brian Gallagher, Ph.D. | Director |
| David Goldfarb | Director, Executive |
| Thomas Hughes | Executive |
| Richard Lundberg | Executive |
| Rick Lundberg | Executive |
| David Madden | Director |
| Marian Nakada | Director |
| Marian Nakada, Ph.D. | Director |
| Vinzenz Ploerer | Director |
| George P. Vlasuk | Director, Executive |
| Georg Vlasuk | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1030 Massachusetts Avenue, Suite 410
Cambridge, MA, 02138
Cambridge, MA, 02138